About
CRF2 agonists, small molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
370
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06815471Lead Sponsor
CRF2 Agonist for the Treatment of Worsening Heart Failure
PHASE2Recruiting
300 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
NCT06399419Collaborator
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
PHASE1Recruiting
28 participants
Started: Jun 19, 2024 · Completed: Oct 19, 2026
NCT05747820Lead Sponsor
Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure
N/ACompleted
42 participants
Started: Sep 28, 2022 · Completed: Apr 27, 2023
Locations (1)
Headquarters
Paris, France
Map
Loading map...